
Haloperidol Tablets
Form: Tablets
Strength: 0.5 mg, 1 mg, 2 mg, 5 mg, 10 mg, 20 mg
Reference Brands: Haldol®(US)
Category: Antipsychotropic Drugs
Haloperidol tablets are FDA-approved in the United States for treating schizophrenia, acute psychosis, and Tourette’s syndrome. In the European Union, they are authorized in various member states under national or decentralized procedures for similar psychiatric conditions. Regulatory submissions must meet GMP standards, include bioequivalence data, and provide robust safety documentation addressing risks like QT prolongation, extrapyramidal symptoms, and neuroleptic malignant syndrome. U.S. labeling must comply with FDA boxed warning requirements. EU filings must include Risk Management Plans (RMPs) and pharmacovigilance systems. To explore dossier-ready Haloperidol tablets and other forms, visit Pharmatradz.com — your trusted B2B pharmaceutical partner.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Risperidone Long-Acting Injection
Strength: 12.5 mg, 25 mg, 37.5 mg, 50 mg vials/syringes
Form: Long-Acting Injection
Reference Brands: Risperdal Consta(US &EU)
View Details Get EnquiryZuclopenthixol ong-acting IM Injection (Depot)
Strength: 200 mg/mL, 500 mg/mL
Form: Long-acting IM Injection (Depot)
Reference Brands: Clopixol Depot®(US)
View Details Get EnquiryZuclopenthixol Short-acting Intramuscular Injection
Strength: 50 mg/mL
Form: Short-acting Intramuscular Injection
Reference Brands: Clopixol-Acuphase®
View Details Get EnquiryZuclopenthixol tablets
Strength: 10 mg, 25 mg, 40 mg
Form: Oral Tablets
Reference Brands: Clopixol®(EU)
View Details Get Enquiry